News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Ives Jeffrey L.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/18/2023 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns:
| Sold 39,149 shares
@ $6.48, valued at
$253.7k
Sold 2,800 shares
@ $6.66, valued at
$18.6k
Exercised 39,149 options to buy
@ $0.72, valued at
$28.2k
Exercised 2,800 options to buy
@ $1.19, valued at
$3.3k
|
|
06/07/2023 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns:
| Granted 25,000 options to buy
@ $5.2, valued at
$130k
|
|
07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns:
| Granted 25,000 options to buy
@ $3.59, valued at
$89.8k
|
|
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/16/2021 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 8,180 shares
@ $16.04, valued at
$131.2k
|
|
07/02/2021 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns:
| Granted 34,000 options to buy
@ $16, valued at
$544k
|
|
06/30/2021 |
3
| Ives Jeffrey L. (Director) has filed a Form 3 on Acumen Pharmaceuticals, Inc. |
06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/24/2020 |
4/A
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 2,500 shares
@ $15.749, valued at
$39.4k
|
|
11/23/2020 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Granted 2,500 shares
@ $15.749, valued at
$39.4k
|
|
06/08/2020 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Granted 7,200 shares
@ $0 Granted 10,800 options to buy
@ $15.62, valued at
$168.7k
|
|
06/03/2020 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 1,000 shares
@ $16, valued at
$16k
Exercised 1,000 options to buy
@ $9.94, valued at
$9.9k
|
|
05/14/2020 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 2,500 shares
@ $16, valued at
$40k
Exercised 2,500 options to buy
@ $9.94, valued at
$24.9k
|
|
04/21/2020 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 2,500 shares
@ $16, valued at
$40k
Exercised 2,500 options to buy
@ $9.94, valued at
$24.9k
|
|
03/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2020 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 2,500 shares
@ $16.23, valued at
$40.6k
Exercised 2,500 options to buy
@ $9.94, valued at
$24.9k
|
|
01/06/2020 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 2,500 shares
@ $16.13, valued at
$40.3k
Exercised 2,500 options to buy
@ $9.94, valued at
$24.9k
|
|
12/04/2019 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 2,500 shares
@ $25.83, valued at
$64.6k
Exercised 2,500 options to buy
@ $5.32, valued at
$13.3k
|
|
11/05/2019 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 2,500 shares
@ $20.68, valued at
$51.7k
Exercised 2,500 options to buy
@ $5.32, valued at
$13.3k
|
|
10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/05/2019 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 2,500 shares
@ $23.31, valued at
$58.3k
Exercised 2,500 options to buy
@ $5.32, valued at
$13.3k
|
|
08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/03/2019 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Sold 2,500 shares
@ $21.75, valued at
$54.4k
Exercised 2,500 options to buy
@ $5.32, valued at
$13.3k
|
|
06/06/2019 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Granted 6,000 shares
@ $0 Granted 9,000 options to buy
@ $20.44, valued at
$184k
|
|
06/08/2018 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Granted 18,000 options to buy
@ $16.07, valued at
$289.3k
|
|
06/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/17/2016 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.
Txns:
| Granted 15,000 options to buy
@ $5.32, valued at
$79.8k
|
|
|
|